Page last updated: 2024-08-17

nad and MODS

nad has been researched along with MODS in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bi, W; Campagnolo, C; Cao, Y; Chapman, G; Choy, KW; Cuny, H; Drysdale, T; Dunwoodie, SL; Flores-Daboub, JA; Iyer, KR; Leung, TN; Liu, P; Siu, VM; Szot, JO; Westerfield, L; Xiao, R1
Ai, ML; Ai, YH; Ma, XH; Peng, QY; Zhang, LN; Zou, Y1
Border, J; Caruana, J; Cerra, F; Hassett, J; McMenamy, R; Moyer, E; Peters, D; Siegel, J; Yu, L1
Caputi, AP; Ciriaco, E; Costantino, G; Cuzzocrea, S; de Sarro, A; de Sarro, G; LaurĂ , R; Mazzon, E1
Inoue, T; Kamiyama, Y; Kitade, H; Kwon, AH; Satoi, S; Takahashi, H; Takahashi, K; Wei, T1
Cairns, CB1

Reviews

1 review(s) available for nad and MODS

ArticleYear
Rude unhinging of the machinery of life: metabolic approaches to hemorrhagic shock.
    Current opinion in critical care, 2001, Volume: 7, Issue:6

    Topics: Energy Metabolism; Humans; Ischemia; Mitochondria; Mitochondrial Diseases; Multiple Organ Failure; NAD; Oxygen Consumption; Reperfusion Injury; Shock, Hemorrhagic; Systemic Inflammatory Response Syndrome; Tumor Necrosis Factor-alpha

2001

Trials

1 trial(s) available for nad and MODS

ArticleYear
Nitric oxide production and hepatic dysfunction in patients with postoperative sepsis.
    Clinical and experimental pharmacology & physiology, 2000, Volume: 27, Issue:3

    Topics: Aged; Female; Humans; Ketone Bodies; Liver Diseases; Male; Mitochondria, Liver; Multiple Organ Failure; NAD; Nitrates; Nitric Oxide; Nitrites; Postoperative Complications; Sepsis

2000

Other Studies

4 other study(ies) available for nad and MODS

ArticleYear
Bi-allelic Mutations in NADSYN1 Cause Multiple Organ Defects and Expand the Genotypic Spectrum of Congenital NAD Deficiency Disorders.
    American journal of human genetics, 2020, 01-02, Volume: 106, Issue:1

    Topics: Alleles; Amino Acid Sequence; Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor; Congenital Abnormalities; Female; Genotype; Gestational Age; Humans; Infant; Infant, Newborn; Male; Multiple Organ Failure; Mutation, Missense; NAD; Pedigree; Phenotype; Pregnancy; Sequence Homology

2020
Blocking NAD(+)/CD38/cADPR/Ca(2+) pathway in sepsis prevents organ damage.
    The Journal of surgical research, 2016, Volume: 201, Issue:2

    Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Animals; Calcium; Calcium Signaling; Cyclic ADP-Ribose; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Malondialdehyde; Membrane Glycoproteins; Multiple Organ Failure; NAD; Random Allocation; Rats, Sprague-Dawley; Sepsis; Superoxide Dismutase

2016
Multiple systems organ failure: mechanisms and therapy.
    Surgery annual, 1982, Volume: 14

    Topics: Acute Kidney Injury; Albumins; Amino Acids; Bacterial Infections; Glucose; Heart Arrest; Humans; Liver; Liver Cirrhosis; Multiple Organ Failure; NAD; Nutrition Disorders; Prospective Studies; Serum Albumin; Wounds and Injuries

1982
Role of interleukin-6 in a non-septic shock model induced by zymosan.
    European cytokine network, 1999, Volume: 10, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Ascites; Ascitic Fluid; DNA Damage; Energy Metabolism; Injections, Intraperitoneal; Interleukin-6; Intestine, Small; Leukocyte Count; Lipid Peroxidation; Liver; Lung; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; NAD; Neutrophils; Nitrates; Nitrites; Oxidative Phosphorylation; Peritonitis; Peroxidase; Shock; Tyrosine; Zymosan

1999